Description_x000D_ Packaging_x000D_ 5, 25 mg in glass bottle_x000D_ Biochem/physiol Actions_x000D_ NSC156529 is a potent inhibitor of Akt/PKB pathway that decreases the proliferation of human cancer cells in vitro, and inhibits tumor growth in a prostate tumor xenograft model. NSC156529 inhibits interaction of PDPK1 and AKT1 by direct binding to PDPK1. NSC156529 increases the differentiation status of cancer cells.